Steno Diabetes Center Copenhagen

Medicin og biovidenskab

1. Type 2 Diabetes Mellitus 100%
2. Type 1 Diabetes Mellitus 92%
3. Glucose 43%
4. Denmark 31%
5. Insulin 30%
6. Placebos 24%
7. Chronic Renal Insufficiency 24%
8. Liraglutide 22%
9. Kidney 20%
10. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 19%
11. Randomized Controlled Trials 19%
12. Albuminuria 19%
13. Glucagon-Like Peptide-1 Receptor 19%
14. Cardiovascular Diseases 18%
15. Hypoglycemia 18%
16. Health 16%
17. BAY 94-8862 16%
18. Cohort Studies 16%
19. Glucagon-Like Peptide 1 15%
20. Glomerular Filtration Rate 15%
21. Biomarkers 14%
22. Blood Pressure 14%
23. Child 14%
24. Obesity 14%
25. Diabetic Nephropathies 14%
26. Glucagon 13%
27. Mortality 13%
28. Therapeutics 13%
29. Population 13%
30. Albumins 13%
31. Exercise 13%
32. Insulin Resistance 12%
33. Gestational Diabetes 11%
34. Self-Management 11%
35. Prediabetic State 11%
36. Fasting 11%
37. Metabolomics 11%
38. Metformin 11%
39. Cross-Over Studies 11%
40. Sodium-Glucose Transport Proteins 11%
41. Body Mass Index 11%
42. Creatinine 10%
43. Systematic Reviews 10%
44. Weight Loss 10%
45. Lipids 10%
46. Lipidomics 10%
47. Overweight 10%
48. Fats 9%
49. Life Style 9%
50. Genome-Wide Association Study 9%
51. Education 9%
52. Hyperglycemia 9%
53. semaglutide 9%
54. Heart Failure 9%
55. Meta-Analysis 8%
56. Confidence Intervals 8%
57. Pregnancy 8%
58. Health Promotion 8%
59. Diabetes Complications 8%
60. Diet 8%
61. Body Composition 7%
62. Peptides 7%
63. Greenland 7%
64. Cross-Sectional Studies 7%
65. Delivery of Health Care 7%
66. Proteomics 7%
67. Body Weight 7%
68. Meals 7%
69. Incidence 7%
70. Glucose Tolerance Test 6%
71. Genes 6%
72. Liver 6%
73. Kidney Diseases 6%
74. Mothers 6%
75. Health Literacy 6%
76. Weights and Measures 6%
77. Incretins 6%
78. Alzheimer Disease 6%
79. Non-alcoholic Fatty Liver Disease 6%
80. Adipose Tissue 6%
81. Diabetic Retinopathy 6%
82. Eating 6%
83. Carbohydrates 6%
84. Linear Models 5%
85. Quality of Life 5%
86. Safety 5%
87. Chronic Kidney Failure 5%
88. Insulin Secretion 5%
89. Diabetic Foot 5%
90. Heart Rate 5%
91. Urine 5%
92. Guidelines 5%
93. Gastric Bypass 5%
94. Twins 5%
95. empagliflozin 5%
96. Diabetic Neuropathies 5%
97. Serum 5%
98. Bile Acids and Salts 5%
99. Sodium-Glucose Transporter 2 Inhibitors 5%
100. Prospective Studies 5%